-
Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $50.00 at BMO Capital Markets
ソース: Buzz FX / 10 1 2025 10:33:15 America/New_York
Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $50.00 at BMO Capital Markets Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective
Read more...